[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342774-105":59,"doc-detail-342774-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","irradiated-microparticles-suppress-prostate-cancer-by-tumor-microenvironment-reprogramming-and-ferroptosis","Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis","","Immunogenic cell death (ICD) is essential for initiating antitumor immune responses within the tumor microenvironment (TME), and ferroptosis is a specialized ICD driven by intracellular iron. However, for immune-desert cancers such as prostate cancer, therapies that robustly induce ferroptosis remain scarce. This study develops radiated tumor cell-derived microparticles (RMPs) delivering the ferroptosis inducer RSL-3, with the CT20 peptide added to further amplify ferroptosis and promote proinflammatory immune reprogramming. In vitro and in vivo results show impaired tumor growth, increased dendritic activation and CD8+ T cell infiltration, and improved efficacy with anti-PD-1.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/irradiated-microparticles-suppress-prostate-cancer-by-tumor-microenvironment-reprogramming-and-ferroptosis/342774/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/irradiated-microparticles-suppress-prostate-cancer-by-tumor-microenvironment-reprogramming-and-ferroptosis/342774.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the core therapeutic strategy tested in this study?","Question",{"text":112,"@type":113},"The study loads the ferroptosis inducer RSL-3 into radiated tumor cell-derived microparticles (RMPs), and additionally includes the CT20 peptide to aggravate ferroptosis and strengthen antitumor immunity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do the CT20-loaded RMPs affect tumor cells and immune signaling?",{"text":117,"@type":113},"CT20 amplifies ferroptosis by increasing ROS production, lipid hydroperoxide levels, and mitochondrial instability; it also elevates dendritic cell markers (MHCII, CD80, CD86) and drives macrophage polarization toward a proinflammatory M1 phenotype.",{"name":119,"@type":110,"acceptedAnswer":120},"Does the therapy work in vivo, and how is it evaluated?",{"text":121,"@type":113},"In a subcutaneously transplanted RM-1 tumor model in mice, RC@RMPs suppress tumor growth and prolong survival via dendritic cell activation, macrophage reprogramming, enhanced CD8+ T cell infiltration, and increased proinflammatory cytokine production; anti-PD-1 combination further improves inhibition.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342774,1790725228,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Deng et al. Journal of Nanobiotechnology (2024) 22:225  \n[https://doi.org/10.1186/s12951-024-02496-3](https://doi.org/10.1186/s12951-024-02496-3)  \nJournal of Nanobiotechnology  \n RESEARCH Open Access  \nIrradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis  \nZihan Deng1†, Binghui Li2,3†, Muyang Yang4†, Lisen Lu4, Xiujuan Shi4, Jonathan F. Lovell5, Xiantao Zeng2,3*, Weidong Hu 1* and Honglin Jin4*  \nAbstract  \nImmunogenic cell death (ICD) plays a crucial role in triggering the antitumor immune response in the tumor microenvironment (TME) . Recently, considerable attention has been dedicated to ferroptosis, a type of ICD that is induced by intracellular iron and has been demonstrated to change the immune desert status oftheTME. However,  \namong cancers that are characterized by an immune desert, such as prostate cancer, strategies for inducing high levels offerroptosis remain limited. Radiated tumor cell-derived microparticles (RMPs) are radiotherapy mimetics that have been shown to activate the cGAS-STING pathway, induce tumor cell ferroptosis, and inhibit M2 macrophage polarization. RMPs can also act as carriers of agents with biocompatibility. In the present study, we designed a therapeutic system wherein the ferroptosis inducer RSL-3 was loaded into RMPs, which were tested in in vitro and in vivo prostate carcinoma models established using RM-1 cells. The apoptosis inducer CT20 peptide (CT20p) was also added to the RMPs to aggravate ferroptosis. Our results showed that RSL-3-and CT20p-loaded RMPs (RC@RMPs) led to ferroptosis and apoptosis of RM-1 cells. Moreover, CT20p had a synergistic effect on ferroptosis by promoting reactive oxygen species (ROS) production, lipid hydroperoxide production, and mitochondrial instability. RC@RMPs elevated dendritic cell (DC) expression of MHCII, CD80, and CD86 and facilitated M1 macrophage polarization. In a subcutaneously transplanted RM-1 tumor model in mice, RC@RMPs inhibited tumor growth and prolonged survival time via DC activation, macrophage reprogramming, enhancement of CD8+ T cell infiltration, and proinflammatory cytokine production in the tumor. Moreover, combination treatment with anti-PD-1 improved RM-1 tumor inhibition. This study provides a strategy for the synergistic enhancement offerroptosis for prostate cancer immunotherapies.  \nKeywords Cancer immunotherapy, Microparticle, Ferroptosis, Immunogenic cell death, Tumor microenvironment, Macrophage reprogramming  \n†Zihan Deng, Binghui Li and Muyang Yang have contributed equally to this work.  \n*Correspondence: Xiantao Zeng  \nzengxiantao1 [128@whu.edu.cn](128@whu.edu.cn)  \nWeidong Hu [huwd@whu.edu.cn](huwd@whu.edu.cn)[ ](huwd@whu.edu.cn)Honglin Jin [jin@hust.edu.cn](jin@hust.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[http:","cbCaif6X1Zs3UYrK","https://ap.wps.com/l/cbCaif6X1Zs3UYrK","pdf",15497588,"English","# Abstract\n# Introduction\n## Prostate cancer background\n## Ferroptosis as immunogenic cell death","[{\"question\":\"What is the core therapeutic strategy tested in this study?\",\"answer\":\"The study loads the ferroptosis inducer RSL-3 into radiated tumor cell-derived microparticles (RMPs), and additionally includes the CT20 peptide to aggravate ferroptosis and strengthen antitumor immunity.\"},{\"question\":\"How do the CT20-loaded RMPs affect tumor cells and immune signaling?\",\"answer\":\"CT20 amplifies ferroptosis by increasing ROS production, lipid hydroperoxide levels, and mitochondrial instability; it also elevates dendritic cell markers (MHCII, CD80, CD86) and drives macrophage polarization toward a proinflammatory M1 phenotype.\"},{\"question\":\"Does the therapy work in vivo, and how is it evaluated?\",\"answer\":\"In a subcutaneously transplanted RM-1 tumor model in mice, RC@RMPs suppress tumor growth and prolong survival via dendritic cell activation, macrophage reprogramming, enhanced CD8+ T cell infiltration, and increased proinflammatory cytokine production; anti-PD-1 combination further improves inhibition.\"}]","Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis | PDF",1790048187,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c090a9080aacb0319c639d04a6a0864.webp",983,1305,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/840efa42ade9c24835f58bea5576e526.webp",982,1304,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20f30bb2a312e83c1337059cdd9c3adc.webp",981,1303,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/139ce6a198d55b74d56ee037fa268f97.webp",980,1301]